KYTX Kyverna Therapeutics, Inc.

Fundamentals / CIK 0001994702 / USD

Kyverna Therapeutics, Inc. reported $189.4M in total assets and a net loss of $157.8M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open KYTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$0$0$0-$150.8MFY 2023 Net Income: -$60.37M2023FY 2024 Net Income: -$127.5M2024FY 2025 Net Income: -$161.3M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Research & Development $133.7M $112.5M $49.92M
Total Operating Expenses $169.8M $142.6M $62.41M
Operating Income -$169.8M -$142.6M -$62.41M
EBITDA -$168.0M -$140.5M -$60.70M
Interest Income $9.09M $15.36M $2.28M
Interest Expense $489K $142K $187K
Income Tax Expense $0 $0 $0
Net Income -$161.3M -$127.5M -$60.37M
Basic EPS -$3.64 -$3.33 -$89.61
Diluted EPS -$3.64 -$3.33 -$89.61
Basic Shares Outstanding 44.3M 38.3M 673.6K
Diluted Shares Outstanding 44.3M 38.3M 673.6K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $27.02M $24.79M $30.07M $30.01M $30.46M $35.82M $37.43M $33.48M
Total Operating Expenses $42.90M $39.56M $41.37M $39.28M $38.73M $44.41M $47.41M $41.04M
Operating Income -$42.90M -$39.56M -$41.37M -$39.28M -$38.73M -$44.41M -$47.41M -$41.04M
EBITDA -$42.62M -$39.12M -$41.02M -$38.91M -$38.31M -$43.90M -$46.91M -$40.48M
Interest Income $1.68M $1.93M $2.33M $1.91M $2.00M $2.36M $2.83M $3.58M
Interest Expense $728K $674K $667K $444K $7.0K $14K $25K $27K
Net Income -$41.94M -$38.32M -$39.73M -$37.80M -$36.79M -$42.08M -$44.63M -$37.49M
Basic EPS -$0.68 -$0.63 -$0.66 -- -$0.85 -$0.97 -$1.03 --
Diluted EPS -$0.68 -$0.63 -$0.66 -- -$0.85 -$0.97 -$1.03 --
Basic Shares Outstanding 62.0M 60.9M 60.4M -- 43.4M 43.2M 43.2M --
Diluted Shares Outstanding 62.0M 60.9M 60.4M -- 43.4M 43.2M 43.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $124.1M $96.62M $34.65M
Short-Term Investments $155.2M $189.4M $22.90M
Cash & Short-Term Investments $279.3M $286.0M $57.54M
Total Current Assets $283.0M $290.6M $60.66M
Property, Plant & Equipment, Net $1.55M $3.35M $2.33M
Other Non-Current Assets $4.90M $2.84M $3.36M
Total Non-Current Assets $10.87M $14.04M $14.53M
Total Assets $293.8M $304.6M $75.19M
Accounts Payable $5.31M $4.62M $4.36M
Total Current Liabilities $36.49M $33.76M $19.86M
Long-Term Debt $24.74M -- --
Total Non-Current Liabilities $25.06M $4.30M $6.16M
Total Liabilities $61.55M $38.06M $26.02M
Total Debt (incl. Leases) $29.03M $8.24M $9.08M
Common Stock $1.0K $0 --
Retained Earnings -$424.8M -$263.5M -$136.0M
Accumulated Other Comp. Income $97K $105K $4.0K
Total Stockholders' Equity $232.3M $266.6M -$13.14M
Total Equity $232.3M $266.6M -$13.14M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $31.82M $31.81M $32.19M $124.1M $34.16M $53.44M $56.87M $96.62M
Short-Term Investments $138.8M $167.6M $204.3M $155.2M $137.0M $158.2M $185.8M $189.4M
Cash & Short-Term Investments $170.6M $199.4M $236.4M $279.3M $171.1M $211.7M $242.6M $286.0M
Total Current Assets $176.3M $206.5M $241.7M $283.0M $174.9M $214.3M $247.7M $290.6M
Property, Plant & Equipment, Net $1.36M $1.33M $1.34M $1.55M $1.79M $2.16M $2.44M $3.35M
Other Non-Current Assets $3.73M $3.44M $5.01M $4.90M $5.36M $4.05M $3.64M $2.84M
Total Non-Current Assets $13.18M $13.28M $15.30M $10.87M $12.23M $12.18M $13.00M $14.04M
Total Assets $189.4M $219.8M $257.0M $293.8M $187.2M $226.5M $260.7M $304.6M
Accounts Payable $3.40M $2.93M $11.60M $5.31M $3.02M $9.92M $8.47M $4.62M
Total Current Liabilities $25.14M $22.80M $29.67M $36.49M $33.87M $39.79M $33.29M $33.76M
Long-Term Debt $24.96M $24.88M -- $24.74M -- -- -- --
Total Non-Current Liabilities $31.15M $31.47M $31.77M $25.06M $1.34M $2.34M $3.35M $4.30M
Total Liabilities $56.28M $54.27M $61.44M $61.55M $35.21M $42.13M $36.65M $38.06M
Total Debt (incl. Leases) $32.45M $33.00M $8.94M $29.03M $5.02M $5.92M $6.94M $8.24M
Common Stock $1.0K $1.0K $1.0K $1.0K -- -- -- $0
Retained Earnings -$544.8M -$502.9M -$464.6M -$424.8M -$387.0M -$350.2M -$308.2M -$263.5M
Accumulated Other Comp. Income -$151K -$142K -$96K $97K $29K -$20K -$1.0K $105K
Total Stockholders' Equity $133.2M $165.5M $195.6M $232.3M $151.9M $184.4M $224.0M $266.6M
Total Equity $133.2M $165.5M $195.6M $232.3M $151.9M $184.4M $224.0M $266.6M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$161.3M -$127.5M -$60.37M
Depreciation & Amortization $1.80M $2.13M $1.71M
Stock-Based Compensation $10.08M $8.36M $2.22M
Change in Payables $543K $736K $4.08M
Operating Cash Flow -$153.7M -$114.2M -$52.41M
Capital Expenditure -$5.0K -$2.21M -$621K
Free Cash Flow -$153.7M -$116.5M -$53.03M
Purchases of Investments -$364.6M -$490.0M -$54.85M
Investing Cash Flow $40.02M -$160.9M -$8.79M
Common Stock Issued $16.94M $0 --
Financing Cash Flow $141.2M $337.1M $58.12M
Net Change in Cash $27.47M $61.96M -$3.08M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$41.94M -$38.32M -$39.73M -$37.80M -$36.79M -$42.08M -$44.63M -$37.49M
Depreciation & Amortization $274K $434K $351K $368K $415K $515K $501K $563K
Stock-Based Compensation $3.62M $3.51M $3.17M $2.70M $2.70M $2.52M $2.16M $1.38M
Change in Payables $469K -$8.65M $6.28M $2.15M -$6.80M $1.41M $3.78M -$5.30M
Operating Cash Flow -$35.37M -$40.31M -$41.60M -$33.53M -$43.32M -$31.95M -$44.91M -$37.06M
Capital Expenditure -- -- -- $1.0K -$2.0K -$4.0K $0 -$532K
Free Cash Flow -- -- -- -$33.53M -$43.32M -$31.95M -$44.91M -$37.59M
Purchases of Investments -$46.15M -$31.92M -$115.9M -$116.0M -$72.82M -$94.73M -$81.12M -$127.2M
Investing Cash Flow $28.52M $36.13M -$50.20M -$17.29M $22.56M $29.17M $5.58M $29.22M
Financing Cash Flow $6.86M $3.79M -$101K $140.7M $1.49M -$649K -$414K -$215K
Net Change in Cash $12K -$388K -$91.90M $89.93M -$19.28M -$3.43M -$39.75M -$8.05M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -69.4% -47.8% --
Return on Assets (ROA) -54.9% -41.8% -80.3%
Current Ratio 7.75x 8.61x 3.05x
Quick Ratio 7.65x 8.47x 2.90x
Debt to Equity 0.12x 0.03x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -118.5% -92.2% -80.0% -69.4% -106.0% -86.1% -64.9% -47.8%
Return on Assets (ROA) -83.3% -69.4% -60.9% -54.9% -86.0% -70.1% -55.8% -41.8%
Current Ratio 7.01x 9.06x 8.15x 7.75x 5.16x 5.39x 7.44x 8.61x
Quick Ratio 6.79x 8.74x 7.97x 7.65x 5.05x 5.32x 7.29x 8.47x
Debt to Equity 0.24x 0.20x 0.05x 0.12x 0.03x 0.03x 0.03x 0.03x
Source: SEC EDGAR CompanyFacts (CIK 0001994702) · from March 31, 2023 Data through September 30, 2026 · synced Nov 20, 2026, 05:40 UTC · Open in terminal